Skip to main content
. 2020 Aug 13;2020:3928504. doi: 10.1155/2020/3928504

Figure 2.

Figure 2

Differences in concentrations of IL-17A, IL-17F, and TNF-α between patients with head and neck cancers depending on T or N parameters. (a) There was a significant difference in salivary concentration of IL-17A (p < 0.001) between patients with different sizes of primary tumor; post-hoc tests showed significant differences between stage T4 patients and T1-T2 as well as T3 patients. (b) There was a significant difference in salivary concentration of TNF-α (p < 0.05) between stages and post hoc tests showed significant differences between stage T4 patients and T1-T2 patients. (c) There was a significant difference in salivary concentration of IL-17A (p < 0.01) between stages and post hoc tests showed significant differences between N2-N3 patients and N0 patients. (d) There was a significant difference in salivary concentration of IL-17F (p < 0.05) between stages, and post hoc tests showed significant differences between N2-N3 patients and N0 patients. (e) There was a significant difference in salivary concentration of TNF-α (p < 0.05) between stages, and post hoc tests showed significant differences between N1 patients and N0 patients. ∗p < 0.05, ∗∗∗p < 0.001, _median.